Is abrdn Life Sciences Investors (HQL) Halal?
Shariah Screening — 5 Standards
Based on financial data from September 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | Excluded — Asset Management | ✗ NOT HALAL | |||
| DJIM | Excluded — Asset Management | ✗ NOT HALAL | |||
| MSCI | Excluded — Asset Management | ✗ NOT HALAL | |||
| S&P | Excluded — Asset Management | ✗ NOT HALAL | |||
| FTSE | Excluded — Asset Management | ✗ NOT HALAL | |||
Financial Highlights
Profitability
| Gross Margin | 100.0% | |
| Operating Margin | -346.8% | |
| Net Margin | 4415.7% | |
| Return on Equity (ROE) | 17.6% | |
| Return on Assets (ROA) | -0.4% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $32M |
| Free Cash Flow | $32M |
| Current Ratio | 0.7 |
| Total Assets | $515M |
Price & Trading
| Last Close | $16.54 |
| 50-Day MA | $16.73 |
| 200-Day MA | $15.52 |
| Avg Volume | 128K |
| Beta | 0.8 |
|
52-Week Range
$10.55
| |
About abrdn Life Sciences Investors (HQL)
Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.
Related Halal Stocks in Financial Services
Frequently Asked Questions
Is abrdn Life Sciences Investors (HQL) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), abrdn Life Sciences Investors is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is abrdn Life Sciences Investors's debt ratio?
abrdn Life Sciences Investors's debt ratio is not available under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%.
What are abrdn Life Sciences Investors's key financial metrics?
abrdn Life Sciences Investors has a market capitalization of $475M, trailing P/E ratio of 5.8, and revenue of $86M. The company maintains a gross margin of 100.0% and a net margin of 4415.7%. Return on equity stands at 17.6%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.